Does EZETIMIBE\SIMVASTATIN Cause Off label use? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Off label use have been filed in association with EZETIMIBE\SIMVASTATIN. This represents 2.5% of all adverse event reports for EZETIMIBE\SIMVASTATIN.
49
Reports of Off label use with EZETIMIBE\SIMVASTATIN
2.5%
of all EZETIMIBE\SIMVASTATIN reports
0
Deaths
19
Hospitalizations
How Dangerous Is Off label use From EZETIMIBE\SIMVASTATIN?
Of the 49 reports, 19 (38.8%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\SIMVASTATIN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE\SIMVASTATIN Cause?
Myalgia (244)
Acute kidney injury (132)
Rhabdomyolysis (113)
Drug hypersensitivity (112)
Arthralgia (89)
Diarrhoea (71)
Muscle spasms (70)
No adverse event (68)
Fatigue (66)
Rash (54)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EZETIMIBE\SIMVASTATIN Alternatives Have Lower Off label use Risk?
EZETIMIBE\SIMVASTATIN vs EZOGABINE
EZETIMIBE\SIMVASTATIN vs FACTOR XIII CONCENTRATE
EZETIMIBE\SIMVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
EZETIMIBE\SIMVASTATIN vs FAMCICLOVIR
EZETIMIBE\SIMVASTATIN vs FAMOTIDINE